Shijiazhuang Yiling Pharmaceutical A, a leading Chinese pharmaceutical company, is dedicated to the research, development, and manufacturing of innovative medicines. Its diverse portfolio includes high-quality pharmaceutical products alongside proven Traditional Chinese Medicine (TCM) therapies. The company is committed to enhancing global healthcare through advanced pharmacy and modern medications.
Date confirmed from the official Chinese exchange disclosure timetable.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shijiazhuang Yiling Pharmaceutical A is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shijiazhuang Yiling Pharmaceutical A last reported quarterly earnings on 8/28/2026 (Q2 2026).
Across its last 3 earnings reports, Shijiazhuang Yiling Pharmaceutical A stock moved by ±1.1% on average the following day. The largest reaction was -1.6% on 08/28/2026; 2 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.